The downregulation of COX15 expression by SETD1A disruption is also observed in non-MLL-r leukemia cell lines (U937 and K562) as well as sarcoma cell lines (A673 and RH30) (Figures S2F and S2G). Here, KMT2A is linked to sarcoma.